Mirati Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Mirati Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2023.
Mirati Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $44.6M, a 3.63% increase year-over-year.
Mirati Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $193M, a 21.5% increase year-over-year.
Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $186M, a 64% increase from 2021.
Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 32.2% increase from 2020.
Mirati Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $85.8M, a 54.6% increase from 2019.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$193M	$44.6M	+$1.56M	+3.63%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$191M	$39.4M	+$715K	+1.85%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$190M	$47M	+$4.06M	+9.45%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$186M	$61.6M	+$27.7M	+81.9%	Oct 1, 2022	Dec 31, 2022	10-K	2023-02-28
Q3 2022	$158M	$43M	+$16.1M	+59.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$142M	$38.7M	+$10.7M	+38.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$132M	$42.9M	+$18.2M	+73.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$114M	$33.9M	+$12.1M	+55.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$101M	$26.9M	+$5.18M	+23.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$96.2M	$28M	+$7.18M	+34.6%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	$89M	$24.7M	+$3.16M	+14.6%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$85.8M	$21.7M	+$5.03M	+30.1%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020	$80.8M	$21.8M	+$6.65M	+44%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	$74.2M	$20.8M	+$8.2M	+65.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$66M	$21.6M	+$10.4M	+93.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$55.5M	$16.7M	+$12.4M	+292%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-28
Q3 2019	$43.1M	$15.1M	+$11M	+272%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$32M	$12.6M	+$8.72M	+225%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$23.3M	$11.1M	+$7.47M	+204%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$15.9M	$4.26M	+$2.94M	+223%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018	$12.9M	$4.06M	+$2.58M	+174%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-04
Q2 2018	$10.3M	$3.87M	+$1.65M	+74.3%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-05
Q1 2018	$8.68M	$3.66M	+$1.89M	+107%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-29
Q4 2017	$6.79M	$1.32M	-$1.22M	-48.1%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-26
Q3 2017	$8.01M	$1.48M	-$1.28M	-46.4%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-06
Q2 2017	$9.29M	$2.22M	-$65K	-2.84%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-01
Q1 2017	$9.35M	$1.77M	-$1.27M	-41.9%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-07
Q4 2016	$10.6M	$2.54M	+$196K	+8.37%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-28
Q3 2016	$10.4M	$2.76M	-$44K	-1.57%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-01
Q2 2016	$10.5M	$2.29M	-$504K	-18.1%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-03
Q1 2016	$11M	$3.04M	+$722K	+31.2%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-04
Q4 2015	$10.3M	$2.34M	+$114K	+5.12%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-08
Q3 2015	$10.1M	$2.8M	+$213K	+8.22%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03
Q2 2015	$9.93M	$2.79M	+$1.51M	+117%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-04
Q1 2015	$8.42M	$2.32M	+$1.37M	+145%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-05
Q4 2014	$7.05M	$2.23M	+$1.03M	+86.3%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-09
Q3 2014	$6.02M	$2.59M	+$840K	+48%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-06
Q2 2014	$5.18M	$1.29M	+$1.5M		Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014	$3.68M	$946K	+$484K	+105%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$3.19M	$1.2M			Oct 1, 2013	Dec 31, 2013	10-K	2016-03-09
Q3 2013		$1.75M			Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-10
Q2 2013		-$217K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-08
Q1 2013		$462K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.